Trial intelligence / Profile preview

Tramadol for Opioid Withdrawal

NCT01188421Phase 2Completed

Sponsor
Johns Hopkins University
Start
Oct 2010
Primary completion
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of tramadol in opioid withdrawal (3 arms), sponsored by Johns Hopkins University. Primary endpoint: Clinical Opiate Withdrawal Scale at 14 days. Started Oct 2010; status: completed.

02

Drugs

tramadol
03

Conditions

opioid withdrawal

Beyond the preview

Go deeper on NCT01188421.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01188421.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call